Each 200 mg tablet contains: Doxycycline HCl, eq. to doxycycline 100 mg, Sporulated bacilli (lactic acid producing) 100 Million Spores, Excipients q.s.ad 1 tablet.

Doxi-Tabs® LB100 is indicated for the treatment of infectious diseases caused by Gram (+), Gram (-) bacteria and microorganisms of the Chlamydophila, Mycoplasma and Rickettsia groups sensitive to doxycycline. Among them: Respiratory tract infections such as pharyngitis, tonsillitis, tracheitis, bronchitis and sinusitis; pneumonias and bronchopneumonias; infections of the  urogenital tract such as cystitis, metritis, prostatitis and interstitial nephritis (leptospirosis); intestinal infections; osteoarticular infections; skin infections such as suppurative dermatitis,  abscesses and cellulitis; otitis, pododermatitis, periostitis and gingivitis; borreliosis, Erlichiosis, anaplasmosis, rickettsiosis, brucellosis and brucellosis and leptospirosis.